2021, Number 2
Current knowledge and trends on allergic bronchopulmonary aspergillosis
Language: Spanish
References: 35
Page:
PDF size: 341.79 Kb.
ABSTRACT
Introduction: Allergic bronchopulmonary aspergillosis is an inflammatory lung disease characterized by a hypersensitivity reaction to colonization of the airway by Aspergillus fumigatus in susceptible individuals, generally patients with asthma and cystic fibrosis.Objective: To update knowledge in the diagnosis and management of allergic bronchopulmonary aspergillosis.
Development: A thematic, observational and retrospective bibliographic review was carried out, from December / 2019 to July / 2020. Databases such as PubMed/MEDLINE, SciElo, ReserchGate, Scopus, ScienceDirect, Redalyc, Latindex, Wed of Science and LILACS were accessed, using descriptors in Health Sciences (Aspergillus fumigatus, allergic bronchopulmonary aspergillosis, hypersensitivity, allergic bronchopulmonary aspergillosis, allergic bronchopulmonary aspergillose, pulmonary aspergillosis, pulmonary aspergillus, hypersensitivity, hypersensitivity). Articles written in Spanish, English or Portuguese were included, which reported on the subject related to allergic bronchopulmonary aspergillosis, selected by reading the title, the abstract, the full text and by evaluating the variables (types of methodological design, aspects general methodological characteristics of each of the designs found and the quality of the research). With these criteria, 36 national and international articles were selected that included original articles, bibliographic reviews, intervention studies, journals and statistical yearbooks.
Conclusions: Allergic bronchopulmonary aspergillosis is much more frequent than previously assumed, but it is frequently underdiagnosed and the diagnosis is made late, which worsens the prognosis of these patients. Establishing timely diagnosis and treatment will help prevent the development of serious complications.
REFERENCES
Sehgal IS, Choudhary H, Dhooria S, Aggarwal AN, Bansal S, Garg M, et al. Prevalence of sensitization to Aspergillus flavus in patients with allergic bronchopulmonary aspergillosis. Med. Mycol. 2019 [acceso: 12/03/2020]; 57(3):270-6. Disponible en: Disponible en: https://europepmc.org/article/med/29566248
San Juan Galán JL, Fernández Andreu CM, Martínez Machín G, Perurena Lancha MR, Velar Martínez R, Illnait Zaragozí MT. Emergencia en Cuba de especies de aspergillus resistente a antifúngicos. BOLIPK. 2017 [acceso: 13/02/2020]; 27(13): 98 Disponible en: Disponible en: https://www.researchgate.net/publication/316658867_Emergencia_en_cuba_de_especies_de_Aspergillus_resistente_a_antifungicos
San Juan JL, Fernández CM, Almaguer M, Perurena MR, Martínez GF, Velar RE et al. Sensibilidad in vitro de cepas cubanas de Aspergillus spp. de origen clínico y ambiental. Biomédica. 2017 [acceso: 11/04/2020]; 37: 452-9 Disponible en: Disponible en: https://revistabiomedica.org/index.php/biomedica/article/view/3447
Vitte J, Ranque S, Carsin A, Gomez C, Romain T, Cassagne C, et al. Multivariate Analysis As a Support for Diagnostic Flowcharts inAllergic Bronchopulmonary Aspergillosis : A Proof-of-Concept Study. Front Immunol.2017 [acceso: 12/04/2020]; 8:1019. Disponible en: Disponible en: https://europepmc.org/article/med/28878778
Agarwal R, Sehgal IS, Dhooria S, Aggarwal AN. Developments in the diagnosis and treatment of allergic bronchopulmonary aspergillosis. Expert RevResp Med . 2016 [acceso: 3/03/2020];10(12):1317-1334. Disponible en: Disponible en: https://www.researchgate.net/publication/309214089_Developments_in_the_diagnosis_and_treatment_of_allergic_bronchopulmonary_aspergillosis
Maleki M, Mortezaee V, Hassanzad M, Mahdaviani SA, Poorabdollah M, Mehrian P, et al. Prevalence of Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis Patients using Two Different Diagnostic Criteria.Eur Ann Allergy ClinImmunol. 2019 [acceso: 3/02/2020]; 52(3):104-111 Disponible en: Disponible en: https://europepmc.org/article/med/31702121
Greenberger PA, Smith LJ, Hsu CC, Roberts M, Liotta JL. Analysis of bronchoalveolar lavage in allergic bronchopulmonary aspergillosis: divergent responses of antigen-specific antibodies and total IgE. J. Allergy Clin. Immunol. 1988 [acceso: 3/03/2020];82(2):164-70. Disponible en: Disponible en: https://europepmc.org/article/med/3042837
Peccini L, Pennoni S, Mencarini V, Saponara M, Palladino N, Principi N, et al. A Peculiar Case of Pneumonia due to Mycoplasma pneumoniae in a Child with Cystic Fibrosis and Sensibilization to Aspergillus fumigatus. Pathogens. 2019 [acceso: 20/01/2020];9(1):15. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/31877884/
Moghtaderi M, Farjadian S, Hossieni Teshnizi S, Hadibarhaghtalab M. Allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization in patients with uncontrolled asthma: An experience from Southwestern Iran. Med J Islam RepubIran. 2019 [acceso: 2/02/2020];33:95. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/31696089/
Michel M, Gomez C, Sereme Y, Gouitaa M, Chartier C, Blanchard P, et al. Evaluation of Cellular Responses for the Diagnosis of Allergic Bronchopulmonary Mycosis: A Preliminary Study in Cystic Fibrosis Patients. Front Immunol . 2020 [acceso: 12/05/2020]; 10:3149. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/32117206/
Gothe F, Schmautz A, Häusler K, Tran NB, Kappler M, Griese M. Treating Allergic Bronchopulmonary Aspergillosis with Short-Term Prednisone and Itraconazole in Cystic Fibrosis. J Allergy Clin Immunol Pract. 2020 [acceso: 20/03/2020]; 8(8):2608-2614.e3. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S2213219820301926
Niven RM, Cooley J, Denning DW. Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization. J Asthma. 2012 [acceso: 22/02/2020];49(4):423-33. Disponible en: Disponible en: https://www.tandfonline.com/doi/abs/10.3109/02770903.2012.662568?journalCode=ijas20
Lanternier F, Seidel D, Pagano L, Styczynski J, Mikulska M, Pulcini C, et al. Invasive pulmonary aspergillosis treatment duration in haematology patients in Europe: An EFISG, IDWP-EBMT, EORTC-IDG and SEIFEM survey. Mycoses. 2020 [acceso: 31/01/2020]; 63(5):420-429. Disponible en: Disponible en: https://moh-it.pure.elsevier.com/en/publications/invasive-pulmonary-aspergillosis-treatment-duration-in-haematolog